{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:20:07Z","timestamp":1791264007042,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008386","name":"Marmara University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Laryngeal dystonia (LD) is a focal dystonia affecting laryngeal musculature with no known etiology or cure. The present study evaluated the sociodemographic and clinical features of patients diagnosed with LD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and Methods<\/jats:title>\n                <jats:p>All patients diagnosed with LD at our University Hospital\u2019s Ear, Nose, and Throat Department between January 2017 and July 2023 were retrospectively analyzed. The study included 43 patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of the 43 patients, 19 (44%) were male. At the time of diagnosis, the mean age of the patients was 35.1\u00a0years (ranging from 17 to 65\u00a0years). The mean elapsed time between the first symptom onset and the first diagnosis was 49.2\u00a0months (min. 4\u00a0months, max. 240\u00a0months). Of the participants, 94% had adductor-type LD. None of the patients had a family history of LD. Of the patients, 9 (20%) experienced a life-altering event or trauma just before the onset of symptoms. All patients who consumed alcohol reported symptom relief with alcohol intake. A total of 67.6% of patients stated that their symptoms were triggered by stress. All of our patients received at least one Botulinum toxin injection, with an average of 2.75 dosages per patient.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The gender distribution was approximately equitable between males and females. There was a tendency for men to receive a diagnosis earlier than women following the manifestation of symptoms. A significant number of patients associate the emergence of their symptoms with a stressful event or traumatic experience. This study represents the initial investigation into the sociodemographic characteristics of patients within the Turkish population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00405-024-08688-9","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T02:01:30Z","timestamp":1715047290000},"page":"4265-4271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Demographic and clinical characteristics of our patients diagnosed with laryngeal dystonia"],"prefix":"10.1007","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0366-3099","authenticated-orcid":false,"given":"Orhan","family":"Asya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2603-3866","authenticated-orcid":false,"given":"\u00d6mer Tar\u0131k","family":"Kavak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8492-7991","authenticated-orcid":false,"given":"Hatice \u00d6merciko\u011flu","family":"\u00d6zden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8533-2922","authenticated-orcid":false,"given":"Dilek","family":"G\u00fcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3161-8810","authenticated-orcid":false,"given":"Necati","family":"Enver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"issue":"10","key":"8688_CR1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/02699206.2022.2096483","volume":"37","author":"EW Reid","year":"2022","unstructured":"Reid EW, Nobriga CV (2022) Spasmodic dysphonia: introductory phonetic analyses. Clin Linguist Phon 37(10):883\u201398","journal-title":"Clin Linguist Phon"},{"issue":"6","key":"8688_CR2","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1288\/00005537-198806000-00012","volume":"98","author":"AB Dds","year":"1988","unstructured":"AB Dds  1988 Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases Laryngoscope 98 6 636 640","journal-title":"Laryngoscope"},{"key":"8688_CR3","volume-title":"Spasmodic dysphonia, clinical voice disorders","author":"A Aronson","year":"2009","unstructured":"Aronson A, Bless D (2009) Spasmodic dysphonia, clinical voice disorders. Thieme Medical Publishers, New York"},{"issue":"2","key":"8688_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/lary.22426","volume":"122","author":"SM Cohen","year":"2012","unstructured":"SM Cohen  2012 Prevalence and causes of dysphonia in a large treatment-seeking population Laryngoscope 122 2 343 348","journal-title":"Laryngoscope"},{"issue":"11","key":"8688_CR5","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1097\/01.mlg.0000179174.32345.41","volume":"115","author":"N Roy","year":"2005","unstructured":"N Roy  2005 Voice disorders in the general population: prevalence, risk factors, and occupational impact Laryngoscope 115 11 1988 1995","journal-title":"Laryngoscope"},{"key":"8688_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ebiom.2019.08.075","volume":"48","author":"H Xiong","year":"2019","unstructured":"H Xiong  2019 Computer-aided diagnosis of laryngeal cancer via deep learning based on laryngoscopic images EBioMedicine 48 92 99","journal-title":"EBioMedicine"},{"key":"8688_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1468-1331.2010.03047.x","volume":"17","author":"A Blitzer","year":"2010","unstructured":"A Blitzer 2010 Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series Eur J Neurol 17 28 30","journal-title":"Eur J Neurol"},{"key":"8688_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/lary.27003","volume":"128","author":"A Blitzer","year":"2018","unstructured":"A Blitzer  2018 Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: a 30-year experience Laryngoscope 128 S1 S9","journal-title":"Laryngoscope"},{"issue":"5","key":"8688_CR9","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/mds.26502","volume":"31","author":"GG Putzel","year":"2016","unstructured":"GG Putzel  2016 GNAL mutation in isolated laryngeal dystonia Mov Disord 31 5 750 755","journal-title":"Mov Disord"},{"issue":"2","key":"8688_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/ene.12151","volume":"21","author":"U Walter","year":"2014","unstructured":"U Walter  2014 Sonographic detection of basal ganglia abnormalities in spasmodic dysphonia Eur J Neurol 21 2 349 352","journal-title":"Eur J Neurol"},{"issue":"12","key":"8688_CR11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1212\/WNL.0000000000009140","volume":"94","author":"C Lungu","year":"2020","unstructured":"C Lungu  2020 Defining research priorities in dystonia Neurology 94 12 526 537","journal-title":"Neurology"},{"issue":"5","key":"8688_CR12","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/brain\/awl355","volume":"130","author":"G Defazio","year":"2007","unstructured":"G Defazio A Berardelli M Hallett 2007 Do primary adult-onset focal dystonias share aetiological factors? Brain 130 5 1183 1193","journal-title":"Brain"},{"key":"8688_CR13","doi-asserted-by":"crossref","unstructured":"Simonyan K (2017) Inferior parietal cortex as a hub of loss of inhibition and maladaptive plasticity (S39. 002). AAN Enterprises","DOI":"10.1212\/WNL.88.16_supplement.S39.002"},{"issue":"42","key":"8688_CR14","doi-asserted-by":"publisher","first-page":"26398","DOI":"10.1073\/pnas.2009165117","volume":"117","author":"D Valeriani","year":"2020","unstructured":"D Valeriani K Simonyan 2020 A microstructural neural network biomarker for dystonia diagnosis identified by a DystoniaNet deep learning platform Proc Natl Acad Sci 117 42 26398 26405","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"8688_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.anl.2020.08.013","volume":"48","author":"M Hyodo","year":"2021","unstructured":"M Hyodo  2021 The prevalence and clinical features of spasmodic dysphonia: A review of epidemiological surveys conducted in Japan Auris Nasus Larynx 48 2 179 184","journal-title":"Auris Nasus Larynx"},{"issue":"3","key":"8688_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/mds.870030302","volume":"3","author":"JG Nutt","year":"1988","unstructured":"JG Nutt  1988 Epidemiology of focal and generalized dystonia in Rochester, Minnesota Mov Disord 3 3 188 194","journal-title":"Mov Disord"},{"issue":"11","key":"8688_CR17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1177\/0003489415588557","volume":"124","author":"AB Patel","year":"2015","unstructured":"AB Patel  2015 The Mayo Clinic Arizona spasmodic dysphonia experience: a demographic analysis of 718 patients Ann Otol Rhinol Laryngol 124 11 859 863","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"6","key":"8688_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/lio2.128","volume":"2","author":"CR Watts","year":"2017","unstructured":"CR Watts M Vanryckeghem 2017 Communication-related affective, behavioral, and cognitive reactions in speakers with spasmodic dysphonia Laryngoscope Investig Otolaryngol 2 6 466 470","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"8688_CR19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/lary.24292","volume":"123","author":"TK Meyer","year":"2013","unstructured":"TK Meyer A Hu AD Hillel 2013 Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin Laryngoscope 123 S1 S14","journal-title":"Laryngoscope"},{"issue":"2","key":"8688_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.otot.2004.02.007","volume":"15","author":"L Sulica","year":"2004","unstructured":"L Sulica A Blitzer 2004 Botulinum toxin treatment of spasmodic dysphonia Oper Tech Otolaryngol Head Neck Surg 15 2 76 80","journal-title":"Oper Tech Otolaryngol Head Neck Surg"},{"key":"8688_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000456693","volume":"85","author":"J Lin","year":"2020","unstructured":"J Lin B Sadoughi 2020 Spasmodic dysphonia Adv Neurolaryngol 85 133 143","journal-title":"Adv Neurolaryngol"},{"issue":"4","key":"8688_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00005537-200104000-00011","volume":"111","author":"N Isshiki","year":"2001","unstructured":"N Isshiki  2001 Thyroplasty for adductor spasmodic dysphonia: further experiences Laryngoscope 111 4 615 621","journal-title":"Laryngoscope"},{"issue":"1","key":"8688_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/0194599817705612","volume":"157","author":"T Sanuki","year":"2017","unstructured":"T Sanuki E Yumoto 2017 Long-term evaluation of type 2 thyroplasty with titanium bridges for adductor spasmodic dysphonia Otolaryngol Head Neck Surg 157 1 80 84","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"8688_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/000348940611500203","volume":"115","author":"JA Koufman","year":"2006","unstructured":"JA Koufman  2006 Treatment of adductor-type spasmodic dysphonia by surgical myectomy: a preliminary report Ann Otol Rhinol Laryngol 115 2 97 102","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"12","key":"8688_CR25","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1080\/00016480801965019","volume":"128","author":"K Nakamura","year":"2008","unstructured":"K Nakamura  2008 Surgical treatment for adductor spasmodic dysphonia\u2013efficacy of bilateral thyroarytenoid myectomy under microlaryngoscopy Acta Otolaryngol 128 12 1348 1353","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"8688_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/000348949910800302","volume":"108","author":"GS Berke","year":"1999","unstructured":"GS Berke  1999 Selective laryngeal adductor denervationreinnervation: a new surgical treatment for adductor spasmodic dysphonia Ann Otol Rhinol Laryngol 108 3 227 231","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"4","key":"8688_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.otohns.2008.05.624","volume":"139","author":"CL Ludlow","year":"2008","unstructured":"CL Ludlow  2008 Research priorities in spasmodic dysphonia Otolaryngol Head Neck Surg 139 4 495 505","journal-title":"Otolaryngol Head Neck Surg"},{"key":"8688_CR28","first-page":"121","volume":"78","author":"PF Duffey","year":"1998","unstructured":"Duffey PF et al (1998) The epidemiology of the primary dystonias in the north of England. Adv Neurol 78:121\u2013125","journal-title":"Adv Neurol"},{"key":"8688_CR29","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s004150070094","volume":"247","author":"Group ESoDiEC","year":"2000","unstructured":"Group ESoDiEC (2000) A prevalence study of primary dystonia in eight European countries. J Neurol 247:787\u2013792","journal-title":"J Neurol"},{"issue":"4","key":"8688_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000059525","volume":"21","author":"EC Konkiewitz","year":"2002","unstructured":"EC Konkiewitz  2002 Service-based survey of dystonia in Munich Neuroepidemiology 21 4 202 206","journal-title":"Neuroepidemiology"},{"issue":"11","key":"8688_CR31","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/mds.10615","volume":"18","author":"T Pekmezovi\u0107","year":"2003","unstructured":"T Pekmezovi\u0107  2003 Prevalence of primary late-onset focal dystonia in the Belgrade population Mov Disord 18 11 1389 1392","journal-title":"Mov Disord"},{"issue":"3","key":"8688_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/mds.20674","volume":"21","author":"H Asgeirsson","year":"2006","unstructured":"H Asgeirsson  2006 Prevalence study of primary dystonia in Iceland Mov Disord 21 3 293 298","journal-title":"Mov Disord"},{"key":"8688_CR33","volume-title":"Understanding health inequalities","author":"H Graham","year":"2009","unstructured":"Graham H (2009) Understanding health inequalities. McGraw-Hill Education (UK), London"},{"issue":"8","key":"8688_CR34","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.socscimed.2012.06.006","volume":"75","author":"R Watanabe","year":"2012","unstructured":"R Watanabe H Hashimoto 2012 Horizontal inequity in healthcare access under the universal coverage in Japan; 1986\u20132007 Soc Sci Med 75 8 1372 1378","journal-title":"Soc Sci Med"},{"key":"8688_CR35","unstructured":"Van Doorslaer E, Koolman X, Puffer F (2002) Equity in the use of physician visits in OECD countries: has equal treatment for equal need been achieved. Measuring up: improving health system performance in OECD countries"},{"issue":"4","key":"8688_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1177\/0194599817728521","volume":"157","author":"JM Hintze","year":"2017","unstructured":"Hintze JM et al (2017) Spasmodic dysphonia: a review. Part 1: pathogenic factors. Otolaryngol Head Neck Surg 157(4):551\u2013557","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"7","key":"8688_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1017\/S002221511400142X","volume":"128","author":"N Nerurkar","year":"2014","unstructured":"N Nerurkar T Banu 2014 Spasmodic dysphonia: a seven-year audit of dose titration and demographics in the Indian population J Laryngol Otol 128 7 649 653","journal-title":"J Laryngol Otol"},{"issue":"6","key":"8688_CR38","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jvoice.2014.03.007","volume":"28","author":"T Murry","year":"2014","unstructured":"T Murry 2014 Spasmodic dysphonia: let's look at that again J Voice 28 6 694 699","journal-title":"J Voice"},{"issue":"10","key":"8688_CR39","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1002\/lary.22168","volume":"121","author":"L Childs","year":"2011","unstructured":"L Childs  2011 Patient perceptions of factors leading to spasmodic dysphonia: a combined clinical experience of 350 patients Laryngoscope 121 10 2195 2198","journal-title":"Laryngoscope"},{"issue":"4","key":"8688_CR40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0967-5868(03)00020-1","volume":"10","author":"S Tisch","year":"2003","unstructured":"S Tisch  2003 Spasmodic dysphonia: clinical features and effects of botulinum toxin therapy in 169 patients\u2014an Australian experience J Clin Neurosci 10 4 434 438","journal-title":"J Clin Neurosci"},{"issue":"7","key":"8688_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/000348941112000708","volume":"120","author":"K Tanner","year":"2011","unstructured":"K Tanner  2011 Spasmodic dysphonia: onset, course, socioemotional effects, and treatment response Ann Otol Rhinol Laryngol 120 7 465 473","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"8","key":"8688_CR42","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/lary.21872","volume":"121","author":"LJ White","year":"2011","unstructured":"LJ White  2011 Coprevalence of tremor with spasmodic dysphonia: a case-control study Laryngoscope 121 8 1752 1755","journal-title":"Laryngoscope"},{"issue":"5","key":"8688_CR43","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jvoice.2013.10.022","volume":"29","author":"FX Creighton","year":"2015","unstructured":"FX Creighton  2015 Diagnostic delays in spasmodic dysphonia: a call for clinician education J Voice 29 5 592 594","journal-title":"J Voice"},{"issue":"7","key":"8688_CR44","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/lary.27617","volume":"129","author":"S Guiry","year":"2019","unstructured":"S Guiry A Worthley K Simonyan 2019 A separation of innate and learned vocal behaviors defines the symptomatology of spasmodic dysphonia Laryngoscope 129 7 1627 1633","journal-title":"Laryngoscope"},{"issue":"1","key":"8688_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/cercor\/bhw363","volume":"28","author":"GG Putzel","year":"2018","unstructured":"GG Putzel  2018 Polygenic risk of spasmodic dysphonia is associated with vulnerable sensorimotor connectivity Cereb Cortex 28 1 158 166","journal-title":"Cereb Cortex"},{"key":"8688_CR46","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00415-006-0457-8","volume":"254","author":"M Svetel","year":"2007","unstructured":"M Svetel  2007 Spread of primary dystonia in relation to initially affected region J Neurol 254 879 883","journal-title":"J Neurol"},{"key":"8688_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.parkreldis.2019.05.034","volume":"65","author":"Xavier L de Lima","year":"2019","unstructured":"de Lima Xavier L, Simonyan K (2019) The extrinsic risk and its association with neural alterations in spasmodic dysphonia. Parkinsonism Relat Disord 65:117\u2013123","journal-title":"Parkinsonism Relat Disord"},{"key":"8688_CR48","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1007\/s00415-015-7751-2","volume":"262","author":"DN Kirke","year":"2015","unstructured":"DN Kirke SJ Frucht K Simonyan 2015 Alcohol responsiveness in laryngeal dystonia: a survey study J Neurol 262 1548 1556","journal-title":"J Neurol"},{"key":"8688_CR49","doi-asserted-by":"crossref","unstructured":"Sanuki T (2022) Spasmodic dysphonia: an overview of clinical features and treatment options. Auris Nasus Larynx","DOI":"10.1016\/j.anl.2022.05.012"},{"issue":"4","key":"8688_CR50","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0892-1997(05)80211-5","volume":"9","author":"T Murry","year":"1995","unstructured":"T Murry GE Woodson 1995 Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy J Voice 9 4 460 465","journal-title":"J Voice"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08688-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-024-08688-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08688-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T19:46:19Z","timestamp":1721763979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-024-08688-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["8688"],"URL":"https:\/\/doi.org\/10.1007\/s00405-024-08688-9","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"assertion":[{"value":"28 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Because the study was designed retrospectively, informed consent was not obtained from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}